Cardiac involvement represents a critical prognostic factor in amyloidosis, as it represents a leading cause of morbidity and mortality, in primary light chain amyloidosis, in hereditary and also in wild-type transthyretin amyloidosis. A 54-year-old male was admitted to Emergency Room with complaints of dyspnea, palpitations and diaphoresis.

La Franca E, C.E. (2017). Amyloidosis and device therapy: an open debate. INTERNATIONAL ANGIOLOGY, 497-498 [10.23736/S0392-9590.17.03821-4].

Amyloidosis and device therapy: an open debate

La Franca E;Corrado E;Inga G;Ciaramitaro G;Novo S;Coppola G.
2017

Abstract

Cardiac involvement represents a critical prognostic factor in amyloidosis, as it represents a leading cause of morbidity and mortality, in primary light chain amyloidosis, in hereditary and also in wild-type transthyretin amyloidosis. A 54-year-old male was admitted to Emergency Room with complaints of dyspnea, palpitations and diaphoresis.
La Franca E, C.E. (2017). Amyloidosis and device therapy: an open debate. INTERNATIONAL ANGIOLOGY, 497-498 [10.23736/S0392-9590.17.03821-4].
File in questo prodotto:
File Dimensione Formato  
amyloidosis 2017 (2).pdf

Solo gestori archvio

Dimensione 198.27 kB
Formato Adobe PDF
198.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/298618
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact